Insmed (INSM) Gross Margin (QoQ) (2019 - 2026)

Insmed (INSM) Gross Margin (QoQ) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Insmed 22.60 Bn 21.38 Bn 258.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 126.00
Dec 31, 2025 387.00
Sep 30, 2025 551.00
Jun 30, 2025 -321.00
Mar 31, 2025 212.00
Dec 31, 2024 -238.00
Sep 30, 2024 55.00
Jun 30, 2024 -8.00
Mar 31, 2024 -109.00
Dec 31, 2023 -91.00
Sep 30, 2023 36.00
Jun 30, 2023 -28.00
Mar 31, 2023 83.00
Dec 31, 2022 -215.00
Sep 30, 2022 525.00
Jun 30, 2022 -218.00
Mar 31, 2022 72.00
Dec 31, 2021 -190.00
Sep 30, 2021 211.00
Jun 30, 2021 59.00